Connection

Michael Diamond to SARS Virus

This is a "connection" page, showing publications Michael Diamond has written about SARS Virus.
Connection Strength

0.115
  1. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
    View in: PubMed
    Score: 0.039
  2. The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex. J Virol. 2008 Oct; 82(19):9477-91.
    View in: PubMed
    Score: 0.017
  3. Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b. Adv Exp Med Biol. 2006; 581:115-20.
    View in: PubMed
    Score: 0.014
  4. Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein. Structure. 2005 Jan; 13(1):75-85.
    View in: PubMed
    Score: 0.014
  5. Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Rep Med. 2021 06 15; 2(6):100313.
    View in: PubMed
    Score: 0.011
  6. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. Proc Natl Acad Sci U S A. 2020 12 15; 117(50):32105-32113.
    View in: PubMed
    Score: 0.010
  7. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020 08; 584(7821):443-449.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.